Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

NCT03702309 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03702309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03702309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Recruiting
Start date
August 3, 2017
Completion date
July 6, 2027
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, brca2 mutation, breast cancer, cancer, colon cancer, cowden syndrome, head and neck cancer, kidney cancer, leukemia, lung cancer, lymphoma, lynch syndrome, melanoma, meningioma, mutation, myeloma, ovarian cancer, uterine cancer